Ex-Vivo

Ex-vivo models serve as a powerful bridge between in-vitro testing and clinical trials, offering a scientifically robust way to evaluate both cosmetic and personal care formulations. Conducted in collaboration with accredited laboratories, these studies use ethically sourced human skin and tissue samples to closely replicate physiological conditions. This approach delivers reliable insights into efficacy, safety, absorption, and skin compatibility, strengthening claim substantiation, product development, and regulatory submissions. In the pharmaceutical sector, ex-vivo research extends to drug permeation, penetration, metabolism, and pharmacokinetic studies, providing crucial data for formulation optimization and bioavailability assessments. By combining advanced ex-vivo methodologies with regulatory expertise, NovoBliss Research® ensures a seamless transition from preclinical testing to first-in-human trials, helping companies reduce risks, accelerate timelines, and bring innovative products to market with confidence.